Pharmafile Logo
Pharmafocus logo
Advanced Search

Patented Medicine Prices Review Board

Showing 1 posts of 1 posts found.

Alexion to challenge Canadian price of Soliris in court

September 28, 2015
Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris

Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …

News
The Gateway to Local Adoption Series

Latest content

NHS awards national diabetes education contract to Leicester programme

August 12, 2026

InnoScot highlights NHS Scotland’s progress towards net zero healthcare

August 11, 2026

NHS England approves delayed-release treatment for rare kidney disease

August 10, 2026

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

August 9, 2026

Functional lung imaging offers new possibilities for respiratory care

August 9, 2026